OncLive® On Air cover image

S13 Ep42: Endometrial (Uterine) Cancer 2025 UPDATE

OncLive® On Air

00:00

New Evidence for Doxorubicin Plus Trabectedin

Sam summarizes the LMS04 trial showing improved overall survival with doxorubicin plus trabectedin for leiomyosarcoma.

Play episode from 09:26
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app